ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselGranite Bio AG
Granite Bio AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Granite Bio AG is a biotechnology company developing therapeutic antibodies for inflammatory, autoimmune and fibrotic diseases. Its pipeline includes minokitug, being studied in a Phase 1b trial in patients with inflammatory bowel disease, and GRT-002, a preclinical candidate.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered4
Development of therapeutic antibodies
Development of first-in-class antibodies against inflammation, autoimmunity and fibrosis; pipeline with GRT-001 and GRT-002 for selective immunomodulation and new therapeutic approaches.
Development of therapies for inflammation, autoimmunity and fibrosis
Development of agents against inflammatory, autoimmune and fibrotic diseases; focus on key disease mechanisms, immunomodulation and selective depletion of pathogenic cells.
GRT-001
Therapeutic antibody for the depletion of pro-inflammatory monocytes; Phase 1a completed, currently Phase 1b in inflammatory bowel disease.
GRT-002
Therapeutic antibody against interleukin-3; developed preclinically for autoimmune inflammation, type II inflammation, itch and allergy.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Granite Bio AG

Trust & reputation

ranQ Trust Score of Granite Bio AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Granite Bio AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Granite Bio AG scores 77.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.64.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Granite Bio AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Granite Bio AG scores 26.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.40.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.13.34%
Qualifications+0.00

Granite Bio AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

April 25, 2025Media
Granite Bio debuts with $100 million to tackle autoimmune diseases
startupticker.ch

Knowledge

No knowledge articles yet

Once Granite Bio AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Granite Bio AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Granite Bio AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Granite Bio AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschenvorstadt 36
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-465.152.120
Founded
2021 · 5 years
Last commercial register change
September 18, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    FT
    Ferrosa Therapeutics AG
    Basel
    SP
    Sumitomo Pharma Switzerland GmbH
    Basel
    SL
    S. L. A. Pharma AG
    Basel
    IS
    Immunovant Sciences GmbH
    Basel
    AS
    Autolus Switzerland AG
    Basel
    MB
    MabTree Biologics AG
    Basel
    VT
    Vaderis Therapeutics AG
    Basel
    TA
    Torqur AG
    Basel